Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMDR vs SSRIs for Post-Traumatic Growth in PTSD
NCT06957210Completed
- Start
- May 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in post-traumatic stress disorder (PTSD) (2 arms). Primary endpoint: Post-Traumatic Growth at 6 weeks. Started May 2025; status: completed.
02
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06957210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06957210.